文献速递艾滋病与性传播感染细菌感染、耐药与抗菌药物

路易斯安那州女性报告性传播感染后新发HIV诊断率(2000-2015):对HIV预防的启示

Rates of New Human Immunodeficiency Virus (HIV) Diagnoses After Reported Sexually Transmitted Infection in Women in Louisiana, 2000-2015: Implications for HIV Prevention.
PubMed 文献 · Clin Infect Dis · 2020-01-01

研究利用路易斯安那州STI和HIV登记数据,分析2000-2015年13-59岁女性首次诊断梅毒、淋病或衣原体后的HIV诊断率。结果显示,有STI史的女性HIV诊断率高于无STI女性,但为所有STI女性提供PrEP成本效益不佳,且多数HIV诊断女性无既往STI报告。

要点

  • 梅毒、淋病或衣原体感染后女性HIV诊断率分别为177.3、73.2、35.4/10万人年,均高于无STI女性的22.4。
  • 为所有梅毒或淋病患者提供PrEP成本高昂,且仅部分HIV诊断发生在感染后2年内。
  • 多数新诊断HIV的女性无既往STI报告,提示需结合其他风险因素制定预防策略。

核心结论

  • 女性STI后HIV诊断率较高,但不足以使PrEP具有成本效益,且多数HIV诊断女性无既往STI报告。

研究设计与样本

  • 基于路易斯安那州STI和HIV登记数据的回顾性队列研究,纳入2000-2015年首次诊断梅毒、淋病或衣原体的13-59岁女性,随访至2016年。

主要发现

  • 梅毒、淋病、衣原体感染后HIV诊断率分别为177.3、73.2、35.4/10万人年,无STI女性为22.4/10万人年。

临床怎么用

  • 对梅毒或淋病女性可考虑短期PrEP,但需评估成本效益;多数HIV诊断女性无既往STI,应结合其他风险因素进行筛查和预防。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Human immunodeficiency virus (HIV) prevention interventions for prevention interventions for women include screening, partner notification, promoting condoms, and preexposure prophylaxis (PrEP). Women's risk of acquiring HIV can help guide recommendations. METHODS: We used data from Louisiana's sexually transmitted infection (STI) and HIV registries to study 13- to 59-year-old women following first diagnosis of syphilis, gonorrhea, or chlamydia during 2000-2015. We measured HIV rates reported subsequent to STI (through 2016). Rates for women without STI were estimated by subtracting women with STI from reported cases and from Census estimates for the population. PrEP cost was estimated as $11 000 per year, and effectiveness estimated as 100%. RESULTS: STIs were syphilis (6574), gonorrhea (64 995), or chlamydia (140 034). These 211 603 women had 1 865 488 person-years of follow-up and 969 HIV diagnoses. Women with no STI had 5186 HIV diagnoses over 24 359 397 person-years. HIV rates diagnosis (per 100 000 person-years) were higher for women after syphilis (177.3), gonorrhea (73.2), or chlamydia (35.4) compared to women with no STI (22.4). Providing PrEP to all women diagnosed with syphilis or gonorrhea would cost $7 371 111 000 and could have prevented 546 HIV diagnoses. Limiting PrEP to 1 year after syphilis or gonorrhea diagnosis would cost $963 847 334, but only 143 HIV diagnoses were within 2 years after a syphilis or gonorrhea diagnosis. CONCLUSIONS: Rates of HIV diagnosis were high after women had STI, but not high enough to make PrEP cost-effective for them. Most women diagnosed with HIV did not have previously reported STI.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Newman DR, Rahman MM, Brantley A, et al. Rates of New Human Immunodeficiency Virus (HIV) Diagnoses After Reported Sexually Transmitted Infection in Women in Louisiana, 2000-2015: Implications for HIV Prevention. Clin Infect Dis. 2020. PMID: 30976788. doi:10.1093/cid/ciz303

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。